Fingerpaint's New Guard: Homegrown Leaders Steer Next Growth Chapter

CEDAR KNOLLS, N.J. – February 25, 2026 – Fingerpaint Group, a prominent force in healthcare commercialization, has initiated a significant leadership transition, elevating a slate of veteran insiders to its highest executive roles. The move, which follows a year of record-breaking revenue, sees Bill McEllen step into the Chief Executive Officer position, succeeding founder Ed Mitzen, who will remain a guiding force as an active board member.

The promotions are a clear validation of the agency’s long-standing philosophy of cultivating leadership from within, a strategy that has now placed trusted, homegrown talent at the helm of its next chapter of growth.

A Deliberate Strategy of Internal Succession

In a decisive move that speaks volumes about its corporate culture, Fingerpaint Group has eschewed an external search, instead promoting from its own proven ranks. The leadership changes are the culmination of years of intentional talent development and succession planning. Bill McEllen, the new CEO, is a testament to this approach. Having served as Global President, his history with the company dates back to its formative years, making him a long-time steward of its culture and key partner relationships.

Joining McEllen in the C-suite are Mark Willmann and Tracy Blackwell, both seasoned leaders within the organization. Willmann has been elevated from President of Marketing Services to the newly created role of Group President. This strategic position unifies oversight across all three of the company's core operating segments: Marketing Services, Medical, and Market Access. Blackwell, a nine-year veteran of the company, will take over Willmann's previous domain, ascending from Managing Director to President of Marketing Services, the agency's largest segment.

The strategy was articulated by founder Ed Mitzen, who will continue to shape the company's long-term vision from his new board position. "These promotions are a direct reflection of the investment we've made in our people over many years," Mitzen stated. "We didn't need to look outside these walls. The leaders we needed were already here, already proven, and already trusted by our client partners and colleagues alike. That's not an accident. It's the result of intentional culture-building and succession planning that I'm incredibly proud of."

This people-first approach is deeply embedded in the company's DNA, creating a stable and experienced leadership team that stands in contrast to competitors who often look externally for top-level hires.

Fueled by Record Performance and Strategic Focus

The leadership shuffle is not happening in a vacuum. It is a direct response to, and a driver for, unprecedented growth. The company closed 2025 with its most successful financial performance in history, reporting record revenue that underscores the efficacy of its integrated model. This growth created both the platform and the imperative to install a leadership structure capable of managing its increasing scale and complexity.

The firm's success is built on deep partnerships within the pharmaceutical industry. It currently works with 22 of the top 25 pharma companies, and over 60% of its revenue is generated from Top 50 Pharma clients. This robust client base is heavily focused on the most dynamic and challenging sectors of medicine. Half of all revenue now flows from the high-growth therapeutic areas of oncology, immunology, and neurology, positioning Fingerpaint at the forefront of scientific innovation and patient care. This sustained financial momentum, which includes a ten-year streak on the Inc. 5000 list of fastest-growing private companies, validates the agency’s strategic direction and provides a powerful mandate for its new leaders.

Building an Integrated Commercialization Powerhouse

Further fueling its expansion, Fingerpaint Group has been actively strengthening its capabilities through strategic acquisitions, a growth initiative supported by its partnership with private equity firm Knox Lane since 2020. In 2025, the company completed two significant acquisitions that have been fully integrated into its service offerings.

The acquisition of Blackpoint bolstered the Market Access segment, adding deep expertise in complex areas like 340B program management, contract compliance, and revenue leakage solutions. This move enhances the company's ability to navigate the intricate landscape of patient access and affordability. Later in the year, the addition of L&M Healthcare extended the Medical segment's capabilities, particularly in peer-to-peer marketing and medical communications.

These acquisitions are not just about adding services; they are about creating a seamless commercialization platform. The promotion of Mark Willmann to the unified Group President role is a direct reflection of this strategy. His position creates a single point of strategic coordination, ensuring that clients benefit from a truly integrated approach that spans the full spectrum from clinical development to market access and brand marketing. Willmann's unique background, which combines scientific training with business acumen, makes him particularly suited to lead this charge across the company's increasingly interconnected disciplines.

A Founder's Evolving Vision and the Future

While Ed Mitzen steps back from the daily operations he has overseen since founding the company in 2008, his influence remains integral. His transition to an active board role is designed to ensure the continuity of the core principles that have defined the agency.

Incoming CEO Bill McEllen acknowledged this legacy, framing his new role as one of stewardship and evolution. "Ed built something that most agency founders never achieve: a company with a genuine soul," McEllen said. "My job has been to continually scale that while making sure that the culture, the partner obsession, and the standard of work that got us here don't just survive growth, they drive it."

This sentiment captures the central challenge and opportunity for the new leadership team: to expand the company's reach and capabilities without diluting the cultural "soul" that has been its key differentiator. With a leadership team that was instrumental in building the company's success, a clear strategic vision for integrated growth, and the continued guidance of its founder, Fingerpaint Group appears poised to translate its record-breaking momentum into a new era of industry leadership.

As McEllen affirmed, "This leadership team has earned everything in front of them, and together we are just getting started."